Cargando…
Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489099/ https://www.ncbi.nlm.nih.gov/pubmed/34607571 http://dx.doi.org/10.1186/s12935-021-02220-3 |
| _version_ | 1784578284723372032 |
|---|---|
| author | Jiang, Huihui Xu, Aiqun Xia, Wanli Xia, Xingyuan Li, Pulin Zhang, Binbin Zhu, Ke Zhou, Sijing Wang, Ran |
| author_facet | Jiang, Huihui Xu, Aiqun Xia, Wanli Xia, Xingyuan Li, Pulin Zhang, Binbin Zhu, Ke Zhou, Sijing Wang, Ran |
| author_sort | Jiang, Huihui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8489099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84890992021-10-05 Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis Jiang, Huihui Xu, Aiqun Xia, Wanli Xia, Xingyuan Li, Pulin Zhang, Binbin Zhu, Ke Zhou, Sijing Wang, Ran Cancer Cell Int Correction BioMed Central 2021-10-04 /pmc/articles/PMC8489099/ /pubmed/34607571 http://dx.doi.org/10.1186/s12935-021-02220-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Jiang, Huihui Xu, Aiqun Xia, Wanli Xia, Xingyuan Li, Pulin Zhang, Binbin Zhu, Ke Zhou, Sijing Wang, Ran Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title | Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title_full | Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title_fullStr | Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title_full_unstemmed | Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title_short | Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| title_sort | correction to: nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489099/ https://www.ncbi.nlm.nih.gov/pubmed/34607571 http://dx.doi.org/10.1186/s12935-021-02220-3 |
| work_keys_str_mv | AT jianghuihui correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT xuaiqun correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT xiawanli correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT xiaxingyuan correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT lipulin correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT zhangbinbin correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT zhuke correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT zhousijing correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis AT wangran correctiontonivolumabmonotherapyorcombinationtherapywithipilimumabforlungcancerasystemicreviewandmetaanalysis |